Literature DB >> 31837815

Subtypes of alcohol use disorder in the general population: A latent class analysis.

Mario Müller1, Vladeta Ajdacic-Gross2, Antonio Besi Vetrella3, Martin Preisig4, Enrique Castelao4, Aurélie Lasserre4, Stephanie Rodgers2, Wulf Rössler5, Stefan Vetter6, Erich Seifritz3, Caroline Vandeleur4.   

Abstract

Alcohol use disorders (AUD) are often comorbid with other disorders with high levels of impairment, which is of relevance for the development and the progression of the disease. Evidence shows that AUD varies greatly with regard to its aetiology, which might lead to distinct clinical representations with important implications for treatment. The current study aimed to apply latent class analysis (LCA) techniques to investigate how comorbidity patterns in AUD vary with regard to specific explanatory factors. A Swiss community sample of N=439 individuals with AUD was subjected to LCA in order to find empirical AUD subtypes of comorbid psychiatric conditions. The subtypes were further validated based on a range of external criteria, including clinical and psycho-social factors as well as treatment variables. A three-class solution of empirical subtypes of AUD comorbidity (low, depressive-anxious, and drug-dependent antisocial) provided the best fit to the data. The three AUD subtypes showed homogeneous comorbidity patterns but varied along dimensions of psycho-social risk factors, consumption patterns and consequences as well as treatment history. Our findings provide strong evidence that AUD in non-treated samples can be described as a multidimensional disorder in terms of its comorbidity structure with distinct etiological factors and important consequences for treatment.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol use disorders; Comorbidity; Externalizing disorders; General population; Internalizing disorders; Latent class analysis; Subtyping

Year:  2019        PMID: 31837815     DOI: 10.1016/j.psychres.2019.112712

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Is lower severity alcohol use disorder qualitatively different than more severe manifestations? An evaluation of multivariate symptom clusters.

Authors:  Allen J Bailey; Polly F Ingram; Lindy K Howe; Peter R Finn
Journal:  Addiction       Date:  2022-01-27       Impact factor: 7.256

2.  Examining differential responses to the Take Care of Me trial: A latent class and moderation analysis.

Authors:  Jona R Frohlich; Karli K Rapinda; Michael P Schaub; Andreas Wenger; Christian Baumgartner; Edward A Johnson; Matthijs Blankers; David D Ebert; Heather D Hadjistavropoulos; Corey S Mackenzie; Jeffrey D Wardell; Jason D Edgerton; Matthew T Keough
Journal:  Addict Behav Rep       Date:  2022-06-03

3.  Patterns and temporal change of psychopathological symptoms among inpatients with alcohol use disorder undergoing a twelve-step based treatment.

Authors:  Zsolt Horváth; Mariann Tremkó; Zsolt Fazekas; András Tóth; Zsolt Petke; Judit Farkas; Mark D Griffiths; Zsolt Demetrovics; Róbert Urbán
Journal:  Addict Behav Rep       Date:  2020-09-08

4.  Externalizing personality characteristics define clinically relevant subgroups of alcohol use disorder.

Authors:  Ildikó Kovács; Bernadett I Gál; Zsolt Horváth; Ildikó Demeter; Sándor Rózsa; Zoltán Janka; Róbert Urbán; Zsolt Demetrovics; Bálint Andó
Journal:  PLoS One       Date:  2022-03-18       Impact factor: 3.240

5.  Epidemiology of comorbid hazardous alcohol use and insomnia in 19 185 women and men attending the population-based Tromsø Study 2015-2016.

Authors:  Vendela H Husberg; Laila A Hopstock; Oddgeir Friborg; Jan H Rosenvinge; Svein Bergvik; Kamilla Rognmo
Journal:  BMC Public Health       Date:  2022-04-27       Impact factor: 4.135

6.  Identifying alcohol misuse biotypes from neural connectivity markers and concurrent genetic associations.

Authors:  Tan Zhu; Chloe Becquey; Yu Chen; Carl W Lejuez; Chiang-Shan R Li; Jinbo Bi
Journal:  Transl Psychiatry       Date:  2022-06-16       Impact factor: 7.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.